Network pharmacology combined with GEO database identifying the mechanisms and molecular targets of Polygoni Cuspidati Rhizoma on Peri-implants

Abstract

Peri-implants is a chronic disease leads to the bone resorption and loss of implants. Polygoni Cuspidati Rhizoma (PCRER), a traditional Chinese herbal has been used to treat diseases of bone metabolism. However, its mechanism of anti-bone absorption still remains unknown. We aimed to identify its molecular target and the mechanism involved in PCRER potential treatment theory to Peri-implants by network pharmacology. The active ingredients of PCRER and potential disease-related targets were retrieved from TCMSP, Swiss Target Prediction, SEA databases and then combined with the Peri-implants disease differential genes obtained in the GEO microarray database. The crossed genes were used to protein–protein interaction (PPI) construction and Gene Ontology (GO) and KEGG enrichment analysis. Using STRING database and Cytoscape plug-in to build protein interaction network and screen the hub genes and verified through molecular docking by AutoDock vina software. A total of 13 active compounds and 90 cross targets of PCRER were selected for analysis. The GO and KEGG enrichment analysis indicated that the anti-Peri-implants targets of PCRER mainly play a role in the response in IL-17 signaling, Calcium signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway among others. And CytoHubba screened ten hub genes (MMP9, IL6, MPO, IL1B, SELL, IFNG, CXCL8, CXCL2, PTPRC, PECAM1). Finally, the molecular docking results indicated the good binding ability with active compounds and hub genes. PCRER’s core components are expected to be effective drugs to treat Peri-implants by anti-inflammation, promotes bone metabolism. Our study provides new thoughts into the development of natural medicine for the prevention and treatment of Peri-implants.

Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening

“…Then, we performed molecular docking on these drugs and the VPS16 protein, respectively. The molecular docking results showed that a total of 51 sensitive drugs spontaneously bound to the core target protein VPS16, and there were 19 drugs with strong molecular binding energy and binding energy less than -7 [ 21 ], among which the nine drugs with the strongest binding to VPS16 were ranked according to the binding energy; they were vinorelbine, cyclopamine, HG-6-64-1, midostaurin, OSU-03012, parthenolide, GSK-650394, BMS-509744, and dasatinib. The higher the binding energy, the closer the drug binds to VPS16.…”

Network pharmacology to unveil the mechanism of suanzaoren decoction in the treatment of alzheimer’s with diabetes

“…Finally, the 3D docking results were visualized using PYMOL software and the 2D docking results were visualized using Discovery Studio software 2017. Among them, a docking score AFFINITY <-4.25 KCAL/MOL −1 considered a binding activity between ligand and target, a score <-5.0 KCAL/MOL −1 indicated a better binding activity, and a score <-7.0 KCAL/MOL −1 a strong docking activity between the two [ 27 ].…”

Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Scutellaria barbata plus Hedyotis diffusa herb pair on esophageal squamous cell carcinoma

“…The GSE17351 datasets contained 5 normal samples and 5 tumor samples, the GSE26886 datesets contained 19 normal samples and 9 tumor samples, and the GSE161533 datesets contained 28 normal samples and 28 tumor samples, respectively. DEGs between ESCC patients with normal tissues and tumor tissues were obtained using the "limma" package of R 4.2.1 software according to the screening conditions of "adjusted P value < 0.05" and "|log 2 FC|> 1" [29] . The volcano plot and heat map of the DEGs from three gene chips were then plotted using the "ggplot2" and "pheatmap" package in the R software.…”